United Therapeutics Corpo... (UTHR)
NASDAQ: UTHR
· Real-Time Price · USD
312.86
0.80 (0.26%)
At close: Aug 15, 2025, 3:59 PM
313.13
0.09%
After-hours: Aug 15, 2025, 05:27 PM EDT
United Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 1.59B | 1.9B | 1.7B | 1.55B | 1.36B | 1.25B | 1.21B | 1.11B | 1.07B | 1.16B | 961.2M | 966.8M | 795.2M | 813.3M | 894.8M | 908.5M | 942.2M | 832.3M |
Short-Term Investments | 1.46B | 1.42B | 1.57B | 1.77B | 1.62B | 1.46B | 1.79B | 1.77B | 1.61B | 1.7B | 1.88B | 1.65B | 1.46B | 1.45B | 1.04B | 1.09B | 1.03B | 899M |
Long-Term Investments | 1.92B | 1.71B | 1.48B | 1.28B | 1.33B | 1.49B | 1.91B | 2.06B | 2.02B | 1.77B | 1.32B | 1.44B | 1.64B | 1.56B | 1.65B | 1.51B | 1.33B | 1.43B |
Other Long-Term Assets | 233.3M | 222.4M | 222.1M | 183.6M | 167.9M | 169.1M | 151.8M | 141.7M | 135.3M | 124.5M | 114.3M | 114.8M | 105.8M | 113.3M | 108.2M | 109M | 177M | 171.2M |
Receivables | 379.3M | 322M | 279.3M | 341.8M | 290.7M | 307.3M | 278.9M | 258.6M | 272.7M | 134.5M | 220.4M | 231.7M | 173.4M | 170.5M | 198.7M | 212.8M | 173.4M | 141.1M |
Inventory | 169.2M | 165.4M | 157.9M | 146.7M | 136.5M | 120.2M | 111.8M | 104.3M | 103.3M | 102.5M | 102M | 91M | 89.9M | 88.2M | 93.8M | 96.7M | 89.9M | 92.2M |
Other Current Assets | 229.7M | 131.1M | 169.7M | 185.4M | 220.8M | 113.4M | 166.2M | 220.5M | 158.4M | 92.6M | 219.2M | 118.1M | 165.8M | 60.2M | 100.4M | 76M | 87.1M | 49.7M |
Total Current Assets | 3.83B | 3.94B | 3.87B | 4B | 3.62B | 3.25B | 3.55B | 3.46B | 3.21B | 3.19B | 3.38B | 3.06B | 2.68B | 2.59B | 2.32B | 2.39B | 2.32B | 2.01B |
Property-Plant & Equipment | 1.36B | 1.3B | 1.22B | 1.16B | 1.09B | 1.07B | 1.05B | 992.2M | 938.9M | 896.5M | 861.5M | 840.8M | 791.4M | 784.4M | 780.9M | 726.7M | 715.7M | 713.7M |
Goodwill & Intangibles | 111.5M | 111.7M | 111.9M | 112.1M | 115.2M | 115.4M | 114.2M | 44.4M | 44.5M | 44.5M | 44.5M | 44.5M | 44.6M | 44.6M | 44.6M | 44.7M | 44.7M | 44.7M |
Total Long-Term Assets | 4.08B | 3.8B | 3.49B | 3.12B | 3.1B | 3.25B | 3.62B | 3.56B | 3.47B | 3.15B | 2.66B | 2.73B | 2.86B | 2.77B | 2.85B | 2.66B | 2.53B | 2.63B |
Total Assets | 7.91B | 7.74B | 7.36B | 7.12B | 6.72B | 6.5B | 7.17B | 7.02B | 6.68B | 6.35B | 6.04B | 5.78B | 5.54B | 5.36B | 5.17B | 5.05B | 4.84B | 4.64B |
Account Payables | 432M | 367M | 6M | 363.9M | 325.3M | 305.1M | 5.6M | 333.4M | 292M | 239.7M | 4.1M | 220.1M | 196.6M | 166.4M | 3.8M | 210.5M | 189.8M | 165M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | -305.1M | 327.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | 200M | 300M | 400M | 400M | 400M | 400M | 300M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 95.1M | 154.5M | 93.6M | 109.5M | 107M | 431.4M | -287.3M | 70.1M | 78.3M | 84.9M | 13M | 95.8M | 134.9M | 126.2M | 248M | 109.5M | 121.6M | 137.4M |
Total Current Liabilities | 527.1M | 721.5M | 738.1M | 873.4M | 832.3M | 860.6M | 804.4M | 744.1M | 370.3M | 324.6M | 343.2M | 315.9M | 331.5M | 292.6M | 305.4M | 320M | 311.4M | 302.4M |
Long-Term Debt | n/a | n/a | n/a | n/a | 100M | 200M | 300M | 500M | 800M | 800M | 800M | 800M | 800M | 800M | 800M | 800M | 800M | 800M |
Other Long-Term Liabilities | 207.3M | 215.2M | 181.9M | 148.8M | 93.7M | 96.5M | 77.8M | 67.4M | 100M | 98.2M | 104.6M | 103.5M | 93.4M | 90.9M | 104.8M | 99.2M | 94M | 93.2M |
Total Long-Term Liabilities | 207.3M | 215.2M | 181.9M | 148.8M | 193.7M | 296.5M | 377.8M | 567.4M | 900M | 898.2M | 904.6M | 903.5M | 893.4M | 890.9M | 904.8M | 899.2M | 894M | 893.2M |
Total Liabilities | 734.4M | 936.7M | 920M | 1.02B | 1.03B | 1.16B | 1.18B | 1.31B | 1.27B | 1.22B | 1.25B | 1.22B | 1.22B | 1.18B | 1.21B | 1.22B | 1.21B | 1.2B |
Total Debt | n/a | 200M | 300M | 400M | 500M | 600M | 700M | 800M | 800M | 800M | 800M | 800M | 800M | 800M | 800M | 800M | 800M | 800M |
Common Stock | 800K | 800K | 800K | 700K | 700K | 700K | 700K | 700K | 700K | 700K | 700K | 700K | 700K | 700K | 700K | 700K | 700K | 700K |
Retained Earnings | 7.85B | 7.54B | 7.22B | 6.92B | 6.61B | 6.33B | 6.03B | 5.81B | 5.54B | 5.28B | 5.04B | 4.91B | 4.67B | 4.55B | 4.32B | 4.2B | 4.04B | 3.87B |
Comprehensive Income | n/a | -1.2M | -3.4M | 7.4M | -14.9M | -15.6M | -12.8M | -43.7M | -50.6M | -38.8M | -55.5M | -84.1M | -65.5M | -54.3M | -23M | -20.1M | -18.6M | -16.8M |
Shareholders Equity | 7.17B | 6.81B | 6.44B | 6.1B | 5.7B | 5.34B | 5.98B | 5.71B | 5.41B | 5.12B | 4.8B | 4.56B | 4.32B | 4.18B | 3.96B | 3.83B | 3.64B | 3.45B |
Total Investments | 3.37B | 3.13B | 3.05B | 3.05B | 2.95B | 2.95B | 3.7B | 3.83B | 3.64B | 3.47B | 3.19B | 3.09B | 3.1B | 3.01B | 2.69B | 2.6B | 2.35B | 2.33B |